Healthcare & Life Sciences
Kalsiom
France
seed
seed
Stage
1
Investors
About
Kalsiom develops first-in-class antibodies targeting calcium signaling pathways for the treatment of autoimmune diseases.
Explore Kalsiom's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.